Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Environmental disease process
- Occupational disease process
- Types of biomarkers
- What do we mean by exposure?
- Exposure-biomarker dose relationships
- Toxicokinetics and models
- Modeling the kinetics: simple model
- Model results
- Application of biomarkers: defining biomarker utility
- Example: gasoline additives
- Concern: human health risks
- Purposes of physiologic modeling
- Internal kinetics of an inhalation exposure
- PBTK: model structure
- PBTK: genetic effects on biomarkers
- Inter-individual variation
- Differences by route of entry
- Common biomarkers - different kinetics
- Human laboratory exposures
- Subjects for the MTBE study: Larry to the rescue
- Human exposure study
- Toxicokinetics: MTBE, blood data
- Toxicokinetics: TBA metabolite, blood data
- Toxicokinetic findings
- MTBE acute effects
- Study limitations
- Key points
- Thank you
Topics Covered
- Biomarkers as indicators of exposure, adverse effects or susceptibility for an individual
- Methods of exposure: inhalation, ingestion or skin absorption
- Toxicokinetics as a guide to understanding biomarker behaviour
- Calibration of biomarkers
- Example of using biomarkers for exposure to MTBE in gasoline
- Using a physiologically based toxicokinetic (PBTK) model of MTBE to estimate tissue and biomarker levels
- Metabolic gene-environment interaction in biomarker production
- Using lab exposures to study biomarkers and the dose-response relationship
Talk Citation
Smith, T. (2007, October 1). Biomarkers of exposure [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/NMQI7858.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Thomas Smith has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.